Free Trial

Actuate Therapeutics (ACTU) SEC Filings & 10K Form

Actuate Therapeutics logo
$7.26 +0.27 (+3.86%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$7.26 0.00 (0.00%)
As of 07/25/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Actuate Therapeutics SEC Filings

DateFilerForm TypeView
07/25/2025
3:00 PM
Actuate Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/07/2025
3:37 PM
Actuate Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/30/2025
12:01 PM
Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
12:02 PM
Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
12:03 PM
Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
11:08 AM
Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SCHEDULE 13D/A
06/26/2025
7:11 AM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
1:57 PM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
6:40 AM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
3:15 PM
Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SCHEDULE 13D/A
05/23/2025
3:37 PM
Actuate Therapeutics (Issuer)
THOMSON TODD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Actuate Therapeutics (Issuer)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:09 AM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
11:15 PM
Actuate Therapeutics (Filer)
Form EFFECT
04/16/2025
4:05 PM
Actuate Therapeutics (Filer)
Form 424B3
04/10/2025
4:28 PM
Actuate Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/02/2025
12:41 PM
Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:43 PM
Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
12:44 PM
Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
5:23 AM
Actuate Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2025
5:00 AM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:00 PM
Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/24/2024
3:05 PM
Actuate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/20/2024
7:45 PM
Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4/A
08/20/2024
7:46 PM
Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4/A
08/20/2024
7:46 PM
Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4/A
08/19/2024
7:59 PM
Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
Form SC 13D
08/19/2024
4:25 PM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
8:12 PM
Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:46 PM
Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:49 PM
Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:51 PM
Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:54 PM
Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:56 PM
Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:44 PM
Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 PM
Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
08/14/2024
6:23 PM
Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:23 PM
Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
6:25 PM
Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:26 PM
Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:27 PM
Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:28 PM
Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:29 PM
Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:30 PM
Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:14 PM
Actuate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/14/2024
3:37 PM
Actuate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
2:11 PM
Actuate Therapeutics (Filer)
Form POS EX
08/13/2024
1:50 PM
Actuate Therapeutics (Filer)
Form 424B4
08/12/2024
11:15 PM
Actuate Therapeutics (Filer)
Form EFFECT
08/12/2024
8:45 PM
Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:46 PM
Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:47 PM
Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:48 PM
Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
8:49 PM
Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:57 PM
Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:29 PM
Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM
Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
5:30 PM
Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
12:35 PM
Actuate Therapeutics (Filer)
Form CERT
08/12/2024
10:58 AM
Actuate Therapeutics (Filer)
Form 8-A12B/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ACTU) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners